Kumene kugula Velpatasvir (Epclusa)? Velpatasvir (Velpanat, Velasof): mtengo mu Russia

"Velpatasvir» (velpatasvir) - ndi mankhwala atsopano akupangidwa ndi Inc. Gileadi Izo ntchito pa matenda a chiwindi C. njira maphunziro othandiza watsata 2 ndi genotype 3 matendawa. Ndipo malingana ngati mankhwala kwa iye mphamvu palibe.

Kuphatikiza sofosbuvir (400 mg) velpatasvirom (100 mg) ndi cholinga chake chinali kuthetsa aliyense genotype chiwindi C HIV ndi kupereka 100% chifukwa ngakhale poyamba imachitika mankhwala sanali bwino. Iwo anayamba kupanga mu United States, farmgigantom Giliyadi Inc, ndi alembedwe piritsi, wodziwika ndi dzina "Epklusa".

Sofosbuvir pokonzekera izi kumabwezera mmbuyo RNA polymerase, amene HIV makope RNA ake ndi velpatasvir amakhudza NS5B polymerase, motero linasokonekera oyamba a matupi athu ndi tizilombo maselo yachibadwa.

Kumene kugula velpatasvir ndi sofosbuvir pokonza amaphatikiza?

Kugula mankhwala "Epklusa" kovuta, ngati iwo ali oposa 60 000 mayuro kwa miyezi itatu njira ya chithandizo, kumene monga inu mukudziwa, ambiri odwala basi sangakwanitse. Mwamwayi, mu 2017 kampani ya Giliyadi wapereka Indian kampani Hetero NATCO PHARMA ndi laisensi sanali yekha kubereka chiphatso generics: VELPANAT (NATCO) ndi VELASOF (HETERO). Kugula velpatasvir + sofosbuvir wotheka ku India pa mtengo lamanja.

Ndalamazi odwala ambiri kuphatikiza - sofosbuvir + velpatasvir - lingathe kukopedwa pa intaneti chachikulu Indian distribyutorskoy WWW.HCV24.COM maukonde.

Kuyitanitsa Intaneti generic Epclusa Indian kampani, muyenera kukhala ndi zikalata kutsimikizira kuti mankhwalawa chiwindi m'ma amafuna.

Kotero kuti odwala mulibe kukayikira, tiyeni tinene kuti generic - izo ndi analogue mtheradi kuwasindikiza mankhwala, amene amapangidwa ndi luso kale, choncho silingawafike mtengo chowonjezera pa kafukufuku ndi msika Kukwezeleza. Ndi ichi, osati khalidwe osauka, monga ena amaganizira generics ndi zambiri angakwanitse kuposa mtundu njira.

contraindications

Monga mukuonera, tanthauzo ndi yofunika kwambiri polimbana ndi matenda aakulu. Koma musanayambe kugula "Velpatasvir" kapena osakaniza ake ndi sofosbuvir, muyenera kudziwa kuti akazi ntchito mankhwala pa mimba ndi yoyamwitsa komanso amuna, mu nkhani ya mimba okondedwa, akatswiri musati amalangiza.

Musati mankhwala chida ichi ndi odwala pansi ndi zaka 18, komanso ndi tsankho munthuyo zigawo mankhwala alipo.

Ndi kusamala ntchito mu mankhwala a odwala wamkulu kuposa zaka 65 ndipo akuvutika insufficiency aakulu aimpso.

dosing

Mankhwala "Epklusa", komanso wake angaperekedwe (sofosbuvir velpatasvir +), mtengo ndi njira ntchito zimene takambirana m'nkhani ino, kutenga kamodzi pa tsiku limodzi. The njira ya mankhwala zambiri kumatenga miyezi itatu.

Pamaso pa decompensated matenda enaake (kalasi B ndi C) wodwala tikulimbikitsidwa kuwonjezera panjirayo mpaka masabata 24. Ndipo mu nkhani iyi, mankhwala ikuchitika osakaniza ndi yokonza "ribavirin".

zotsatira zoyipazi

Pamaso pa Inu Gulani "Velpatasvir" kapena osakaniza, ndipo muyenera kudziwa za mavuto omwe angagwe pa ntchito. Choncho, odwala akhoza kuona:

• chizungulire;
• matenda chidwi ndi chikumbukiro;
• kukomoka;
• kufupika kwa mpweya;
• m'mimba;
• magazi m'thupi;
• zotumphukira edema;
• hypothyroidism;
• totupa;
• thupi lawo siligwirizana;
• photosensitivity.

Nthawi ya mankhwala ambiri osokoneza "Velpatasvir", mungagule pa malo okonza sizinachitike anati.